在患有ST段升高心肌梗塞,接受初级PCI的患者中,凝血因子XI活性水平的变化
Marco Spagnolo1, Nicola Ammirabile1, Luigi Cutore1
1Division of Cardiology, A.O.U. Policlinico "G. Rodolico - San Marco" - University of Catania, Catania, Italy.
Thrombosis and haemostasis
|January 27, 2025
概括
在ST升高心肌梗塞 (STEMI) 患者的皮革冠状动脉干预后,XI因子 (FXI) 水平增加. 血栓形成风险因素与FXI活动变化无关,这表明需要个性化抗凝剂治疗.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 血栓形成研究研究
背景情况:
- 对XI因子 (FXI) 抑制剂进行了研究,以预防血栓事件.
- 早期的FXI抑制可以防止ST升高心肌梗塞 (STEMI) 中的血栓巩固.
- 在接受初级穿皮冠状动脉干预 (PCI) 的STEMI患者中,鉴定FXI水平至关重要.
研究的目的:
- 在入院和PCI后的STEMI患者中表征凝血因子XI活性 (FXIa) 水平.
- 为了评估研究期间FXIa水平的变化.
- 确定FXIa变异性的预测因素及其与血栓形成风险的关联.
主要方法:
- 预期招募接受初级PCI的STEMI患者.
- 在入境和出境前测量外汇资产水平.
- 对FXIa变异的分析和与血栓形成风险指标的关联.
主要成果:
- 中位数FXIa显著增加,从入院时的0.865 IU/mL增加到出院前的1.161 IU/mL (+34.2%,p < 0.001).
- 在高和低FXIa可变性组之间没有发现血栓风险指标的显著差异.
- 没有确定高FXIa变化的独立预测因素.
结论:
- 这项研究是首次报告PCI后STEMI患者从入院到出院的FXIa水平增加.
- 标准血栓风险指标与该队列的FXIa水平或变异性无关.
- 这些发现支持进一步研究基于个体凝血状况的患者特异性抗凝剂策略.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
602
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
602
Extrinsic and Intrinsic Pathways of Hemostasis
5.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.0K
Clot Retraction and Fibrinolysis
3.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.6K
Coagulation
4.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.4K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
94
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
94


